Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Residual Disease”

1,267 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,267 results

Not applicableLooking for participantsNCT07420192
What this trial is testing

Evaluation of RPNI for Symptomatic Neuromas in Lower Limb Amputees

Who this might be right for
Symptomatic NeuromaPhantom Limb Pain After AmputationResidual Limb Pain+2 more
Saglik Bilimleri Universitesi 20
Not applicableUnknownNCT03749265
What this trial is testing

Rate Of Residual Clubfoot Deformity With Correlation To Absence Of Peroneus Tertius Muscle

Who this might be right for
Clubfoot
HaEmek Medical Center, Israel 75
Post-approval studies (Phase 4)Study completedNCT00697372
What this trial is testing

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Who this might be right for
Coronary Artery DiseaseCoronary Stenosis
Catholic University of the Sacred Heart 150
Testing effectiveness (Phase 2)Looking for participantsNCT05286957
What this trial is testing

MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC

Who this might be right for
NSCLC
The First Affiliated Hospital of Zhengzhou University 60
Post-approval studies (Phase 4)Study completedNCT00199004
What this trial is testing

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Who this might be right for
Adult Acute Lymphocytic Leukemia
Johann Wolfgang Goethe University Hospital 60
Not applicableNot Yet RecruitingNCT06661928
What this trial is testing

Conservative Surgery with Modified Widman Flap Vs Papilla Preservation Technique for the Treatment of Residual Pockets

Who this might be right for
Periodontitis
University of Turin, Italy 80
Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65
Very early researchActive Not RecruitingNCT04674306
What this trial is testing

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Who this might be right for
Pathologic Stage IIA-IIIC Triple-Negative Breast CancerTNBC - Triple-Negative Breast CancerResidual Disease
George T. Budd 35
Testing effectiveness (Phase 2)Looking for participantsNCT06088381
What this trial is testing

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more
University of Maryland, Baltimore 61
Large-scale testing (Phase 3)Ended earlyNCT00956072
What this trial is testing

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 12
Not applicableNot Yet RecruitingNCT07450534
What this trial is testing

The Practicality and Utility of Measured vs Estimated GFR in adCKD

Who this might be right for
Chronic Kidney Disease (Stages 4 and 5)Chronic Kidney Disease 5D
Manchester University NHS Foundation Trust 150
Not applicableUnknownNCT01402037
What this trial is testing

Beta Cell Function in (Pre)Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Universitair Ziekenhuis Brussel 100
Not applicableUnknownNCT05254821
What this trial is testing

Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
Federico II University 130
Testing effectiveness (Phase 2)Study completedNCT00506077
What this trial is testing

MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Who this might be right for
Paranoid Schizophrenia
Merck Sharp & Dohme LLC 55
Not applicableLooking for participantsNCT06222164
What this trial is testing

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Who this might be right for
Hematologic Diseases
Invivoscribe, Inc. 2,000
Testing effectiveness (Phase 2)Study completedNCT00199030
What this trial is testing

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

Who this might be right for
Adult Acute Lymphocytic Leukemia T-cellLymphoma, Lymphoblastic
Goethe University 8
Testing effectiveness (Phase 2)Study completedNCT01781728
What this trial is testing

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma

Who this might be right for
Pancreatic CancerPeriampullary Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Not applicableStudy completedNCT00329277
What this trial is testing

Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Looking for participantsNCT03965234
What this trial is testing

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Who this might be right for
Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more
Roswell Park Cancer Institute 99
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Load More Results